BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7525961)

  • 21. Cardiovascular effects of noradrenaline in hypovolemic haemorrhage: role of inducible nitric oxide synthase.
    Tabrizchi R
    Eur J Pharmacol; 1998 Nov; 361(2-3):227-34. PubMed ID: 9865512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis.
    Westenfeld R; Gawlik A; de Heer E; Kitahara M; Abou-Rebyeh F; Floege J; Ketteler M
    Kidney Int; 2002 Mar; 61(3):834-8. PubMed ID: 11849434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
    Bryk R; Wolff DJ
    Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL; Moore PK
    Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The modulation of hepatic injury and heat shock expression by inhibition of inducible nitric oxide synthase after hemorrhagic shock.
    Menezes JM; Hierholzer C; Watkins SC; Billiar TR; Peitzman AB; Harbrecht BG
    Shock; 2002 Jan; 17(1):13-8. PubMed ID: 11795663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina.
    Sakamoto K; Yonoki Y; Kubota Y; Kuwagata M; Saito M; Nakahara T; Ishii K
    Exp Eye Res; 2006 Mar; 82(3):512-8. PubMed ID: 16198335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the inducible nitric oxide synthase inhibitors aminoguanidine and L-N6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skin.
    Ridger VC; Pettipher ER; Bryant CE; Brain SD
    J Immunol; 1997 Jul; 159(1):383-90. PubMed ID: 9200477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia.
    Matejovic M; Krouzecky A; Martinkova V; Rokyta R; Kralova H; Treska V; Radermacher P; Novak I
    Shock; 2004 May; 21(5):458-65. PubMed ID: 15087823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
    J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.
    Hansel TT; Kharitonov SA; Donnelly LE; Erin EM; Currie MG; Moore WM; Manning PT; Recker DP; Barnes PJ
    FASEB J; 2003 Jul; 17(10):1298-300. PubMed ID: 12738811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis.
    Mandai M; Mittag TW; Kogishi J; Iwaki M; Hangai M; Yoshimura N
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):826-32. PubMed ID: 8603867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis.
    Gabbai FB; Boggiano C; Peter T; Khang S; Archer C; Gold DP; Kelly CJ
    J Immunol; 1997 Dec; 159(12):6266-75. PubMed ID: 9550431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection.
    Pieper GM; Nilakantan V; Hilton G; Zhou X; Khanna AK; Halligan NL; Felix CC; Kampalath B; Griffith OW; Hayward MA; Roza AM; Adams MB
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H525-34. PubMed ID: 14715498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits.
    Behr-Roussel D; Rupin A; Simonet S; Bonhomme E; Coumailleau S; Cordi A; Serkiz B; Fabiani JN; Verbeuren TJ
    Circulation; 2000 Aug; 102(9):1033-8. PubMed ID: 10961969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of nitric oxide in hepatic microvascular injury elicited by acetaminophen in mice.
    Ito Y; Abril ER; Bethea NW; McCuskey RS
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G60-7. PubMed ID: 12969830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
    Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
    Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis.
    Fischer LG; Freise H; Hilpert JH; Wendholt D; Lauer S; Van Aken H; Sielenkämper AW
    Intensive Care Med; 2004 Sep; 30(9):1821-8. PubMed ID: 15375651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
    Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
    Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition and pharmacokinetics of L-N6-(1-iminoethyl)lysine-5-tetrazole-amide, a selective iNOS inhibitor, in rats.
    Zhang JY; Wang Y; Milton MN; Kraus L; Breau AP; Paulson SK
    J Pharm Sci; 2004 May; 93(5):1229-40. PubMed ID: 15067699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.